Products for Research Use Only
RegisterLogin

Zamerovimab

CAT: 0804-HY-P99513-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99513-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Zamerovimab (CTB011) is an anti-rabies humanized IgG1κ monoclonal antibody that binds to the non-overlapping epitopes on the rabies virus (RABV) glycoprotein. Zamerovimab targets residues at and near antigenic site III. Zamerovimab can be used in rabies studies[1].
CAS Number
2419087-87-7
Product Name Alternative
CTB011
UNSPSC
12352203
Target
RABV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/zamerovimab.html
Solubility
10 mM in DMSO
Smiles
[Zamerovimab]
References & Citations
[1]Tzu-Yuan Chao, et al. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies. PLoS Negl Trop Dis. 2017 Dec 20;11 (12) :e0006133.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T80589-01Zamerovimab
GTR18334224Zamerovimab Antibody
E55B0855Zamerovimab (Reference antibody)
MBS1564080-01Research Grade Zamerovimab
GTR18697278-01Zamerovimab Human Monoclonal Antibody
GTR18780904-01(Zamerovimab) Biosimilar Reference Antibody
ICH6000-25mgZamerovimab Biosimilar - Research Grade
A135563Zamerovimab Biosimilar (Monoclonal, IgG1, kappa)
PX-TA1795-01Zamerovimab Biosimilar - Anti-G Glycoprotein mAb - Research Grade
GS40811-01(Zamerovimab) Biosimilar Reference Antibody (Rabies Virus Spike Glycoprotein G) (CAS NO:2419087-87-7)

Popular Products